Register Now: Image-Based Risk: The Next Frontier in Breast Cancer Screening
|Articles|March 29, 1995

Magna-Lab moves to NASDAQ's OTC board

The stock of niche MRI developer Magna-Lab has been moved to NASDAQ's OTC Bulletin Board due tothe company's failure to meet minimum listing requirements onNASDAQ's Small-Cap exchange. Magna-Lab, of Hicksville, NY, hopesto return to the small-cap market

The stock of niche MRI developer Magna-Lab has been moved to NASDAQ's OTC Bulletin Board due tothe company's failure to meet minimum listing requirements onNASDAQ's Small-Cap exchange. Magna-Lab, of Hicksville, NY, hopesto return to the small-cap market after securing additional fundinglater this year, according to vice president John Haytaian.

Magna-Lab failed to meet NASDAQ's net worth requirement of$1 million for the small-cap market after a private equity placementfell through late last year and the company began using debt tofund operations (SCAN 12/14/94). NASDAQ made the decision to moveMagna-Lab's stock earlier this month. Ironically, Magna-Lab'sstock began moving upward after the move, Haytaian said.

Magna-Lab signed a letter of intent this month for a secondarypublic offering of $5 million to take place in the next two tothree months that will bring the company back into compliancewith NASDAQ requirements. The firm may also complete a privateequity placement by then, according to Haytaian.

The company has been rounding out its stable of distributionpartners for the Magna-SL 0.3-tesla scanner, which received Foodand Drug Administration clearance last year (SCAN 9/28/94). Magna-Labthis month signed an agreement with American Medical Concepts(AMCI) of Houston to distribute Magna-SL to the U.S. orthopedicmarket. The deal will complement an agreement with Beta-Numericsfor the fee-per-scan and mobile markets, as well as a deal withElscint for international sales that has not yet been finalized.

Magna-Lab this month completed the first installation of Magna-SLto MedCenter Imaging in San Antonio, TX. The installation tookonly two days, Haytaian said. Imaging services firm Health Imagesof Atlanta will be under contract by Magna-Lab to provide servicefor that unit, he said.

Related to this article

Emerging Research Insights and New Advances in Neuroradiology
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Current Perspectives on Integrating AI into Radiology
In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.